Agios Pharmaceuticals, Inc. (AGIO)
32.60
-0.49
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
32.33
-0.27
(-0.83%)
After-Hours: 20:00
Agios Pharmaceuticals Total Assets (Quarterly) : 1.108B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.108B |
| March 31, 2026 | 1.185B |
| December 31, 2025 | 1.297B |
| September 30, 2025 | 1.386B |
| June 30, 2025 | 1.471B |
| March 31, 2025 | 1.556B |
| December 31, 2024 | 1.663B |
| September 30, 2024 | 1.792B |
| June 30, 2024 | 773.06M |
| March 31, 2024 | 849.71M |
| December 31, 2023 | 937.12M |
| September 30, 2023 | 1.007B |
| June 30, 2023 | 1.085B |
| March 31, 2023 | 1.151B |
| December 31, 2022 | 1.239B |
| September 30, 2022 | 1.180B |
| June 30, 2022 | 1.252B |
| March 31, 2022 | 1.336B |
| December 31, 2021 | 1.438B |
| September 30, 2021 | 1.541B |
| June 30, 2021 | 1.875B |
| March 31, 2021 | 2.488B |
| December 31, 2020 | 852.95M |
| September 30, 2020 | 908.45M |
| June 30, 2020 | 976.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 799.74M |
| December 31, 2019 | 890.74M |
| September 30, 2019 | 698.62M |
| June 30, 2019 | 783.87M |
| March 31, 2019 | 822.13M |
| December 31, 2018 | 858.46M |
| September 30, 2018 | 929.08M |
| June 30, 2018 | 998.24M |
| March 31, 2018 | 1.040B |
| December 31, 2017 | 614.40M |
| September 30, 2017 | 687.20M |
| June 30, 2017 | 760.60M |
| March 31, 2017 | 557.32M |
| December 31, 2016 | 619.09M |
| September 30, 2016 | 672.04M |
| June 30, 2016 | 557.60M |
| March 31, 2016 | 396.12M |
| December 31, 2015 | 420.06M |
| September 30, 2015 | 449.09M |
| June 30, 2015 | 474.38M |
| March 31, 2015 | 474.34M |
| December 31, 2014 | 491.90M |
| September 30, 2014 | 269.61M |
| June 30, 2014 | 272.03M |
| March 31, 2014 | 181.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Biogen, Inc. | 32.09B |
| Insmed, Inc. | 2.103B |
| Liquidia Corp. | 521.92M |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.40M |
| Shareholders Equity (Quarterly) | 1.026B |
| Debt to Equity Ratio | 0.0304 |
| Current Ratio | 10.22 |
| Net Debt Paydown Yield | 0.20% |